Aortic valve implant ranscateter in severe aortic stenosis
Implante de válvula aórtica ranscateter en estenosis aórtica severa
Article Sidebar
PDF (Español (España))
FLIP
HTML (Español (España))
EPUB (Español (España))
How to Cite
Liévano, J., Villegas, J., Sánchez, J., Ávila, Y., & Montes, L. (2018). Aortic valve implant ranscateter in severe aortic stenosis. Journal of Medicine and Surgery Repertoire, 27(2). https://doi.org/10.31260/RepertMedCir.v27.n2.2018.188
Section
Case Reports
License terms
Main Article Content
Abstract
Objective: to describe the first case of transcatheter aortic valve implantation (TAVI) performed at Hospital Infantil Universitario de San José of Bogotá, in a patient with symptomatic severe degenerative aortic valve stenosis with severe systolic dysfunction. Study Design: a case report. Methodology: a 76-year-old woman referred to the hemodynamics service with clinical suspicion for acute coronary syndrome and symptomatic severe aortic stenosis, considered a suitable candidate for interventional management with TAVI. This is the first case of this procedure performed at the hemodynamics service of said hospital. Conclusion: TAVI is a valid option for patients who are deemed at intermediate, high or extremely high risk of complications from surgical aortic valve replacement. The hemodynamics service of Hospital Infantil Universitario de San José of Bogotá, has the necessary healthcare resources to deliver this type of procedures
Downloads
Download data is not yet available.
Article Details
References
1. Barbanti M, Webb JG, Gilard M, Capodanno D, Tamburino C. Transcatheter aortic valve implantation in 2017: state of the art. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2017;13(AA):AA11-AA21. Epub 2017/09/25.
2. Masri A, Svensson LG, Griffin BP, Desai MY. Contemporary natural history of bicuspid aortic valve disease: a systematic review. Heart. 2017;103(17):1323-30. Epub 2017/05/12.
3. Aboyans V, Ricco JB, Bartelink MEL, Bjorck M, Brodmann M, Cohnert T, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). European heart journal. 2018;39(9):763-816. Epub 2017/09/10.
4. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, et al. Guidelines on the management of valvular heart disease (version 2012). European heart journal. 2012;33(19):2451-96. Epub 2012/08/28.
5. Paredes A, Martínez A. Prótesis valvular aórtica percutánea: ¿Qué debemos saber? Revista chilena de cardiología. 2012;31:55-62.
6. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. The New England journal of medicine. 2010;363(17):1597-607. Epub 2010/10/22.
7. Lauten A, Figulla HR, Mollmann H, Holzhey D, Kotting J, Beckmann A, et al. TAVI for low-flow, low-gradient severe aortic stenosis with preserved or reduced ejection fraction: a subgroup analysis from the German Aortic Valve Registry (GARY). EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2014;10(7):850-9. Epub 2014/11/22.
8. Vahl TP, Kodali SK, Leon MB. Transcatheter Aortic Valve Replacement 2016: A Modern-Day "Through the Looking-Glass" Adventure. Journal of the American College of Cardiology. 2016;67(12):1472-87. Epub 2016/03/26.
9. Sawaya FJ, Deutsch MA, Seiffert M, Yoon SH, Codner P, Wickramarachchi U, et al. Safety and Efficacy of Transcatheter Aortic Valve Replacement in the Treatment of Pure Aortic Regurgitation in Native Valves and Failing Surgical Bioprostheses: Results From an International Registry Study. JACC Cardiovascular interventions. 2017;10(10):1048-56. Epub 2017/05/20.
10. Toggweiler S, Leipsic J, Binder RK, Freeman M, Barbanti M, Heijmen RH, et al. Management of vascular access in transcatheter aortic valve replacement: part 2: Vascular complications. JACC Cardiovascular interventions. 2013;6(8):767-76. Epub 2013/08/24.
11. Barbanti M, Buccheri S, Rodes-Cabau J, Gulino S, Genereux P, Pilato G, et al. Transcatheter aortic valve replacement with new-generation devices: A systematic review and meta-analysis. International journal of cardiology. 2017;245:83-9. Epub 2017/08/02.
2. Masri A, Svensson LG, Griffin BP, Desai MY. Contemporary natural history of bicuspid aortic valve disease: a systematic review. Heart. 2017;103(17):1323-30. Epub 2017/05/12.
3. Aboyans V, Ricco JB, Bartelink MEL, Bjorck M, Brodmann M, Cohnert T, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). European heart journal. 2018;39(9):763-816. Epub 2017/09/10.
4. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, et al. Guidelines on the management of valvular heart disease (version 2012). European heart journal. 2012;33(19):2451-96. Epub 2012/08/28.
5. Paredes A, Martínez A. Prótesis valvular aórtica percutánea: ¿Qué debemos saber? Revista chilena de cardiología. 2012;31:55-62.
6. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. The New England journal of medicine. 2010;363(17):1597-607. Epub 2010/10/22.
7. Lauten A, Figulla HR, Mollmann H, Holzhey D, Kotting J, Beckmann A, et al. TAVI for low-flow, low-gradient severe aortic stenosis with preserved or reduced ejection fraction: a subgroup analysis from the German Aortic Valve Registry (GARY). EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 2014;10(7):850-9. Epub 2014/11/22.
8. Vahl TP, Kodali SK, Leon MB. Transcatheter Aortic Valve Replacement 2016: A Modern-Day "Through the Looking-Glass" Adventure. Journal of the American College of Cardiology. 2016;67(12):1472-87. Epub 2016/03/26.
9. Sawaya FJ, Deutsch MA, Seiffert M, Yoon SH, Codner P, Wickramarachchi U, et al. Safety and Efficacy of Transcatheter Aortic Valve Replacement in the Treatment of Pure Aortic Regurgitation in Native Valves and Failing Surgical Bioprostheses: Results From an International Registry Study. JACC Cardiovascular interventions. 2017;10(10):1048-56. Epub 2017/05/20.
10. Toggweiler S, Leipsic J, Binder RK, Freeman M, Barbanti M, Heijmen RH, et al. Management of vascular access in transcatheter aortic valve replacement: part 2: Vascular complications. JACC Cardiovascular interventions. 2013;6(8):767-76. Epub 2013/08/24.
11. Barbanti M, Buccheri S, Rodes-Cabau J, Gulino S, Genereux P, Pilato G, et al. Transcatheter aortic valve replacement with new-generation devices: A systematic review and meta-analysis. International journal of cardiology. 2017;245:83-9. Epub 2017/08/02.